APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Consortium

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Medical Consortium Market Outlook and Growth Opportunities 2026

28 December 2025191 pages

Choose your research edition.

Industry ResearchMedical Consortium Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Consortium Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Medical Consortium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Consortium Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Consortium Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Medical Consortium market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Medical Consortium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medical Consortium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medical Consortium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Medical Consortium market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Medical Consortium market include Epic Systems Corporation, Cerner Corporation, McKesson Corporation, Allscripts Healthcare Solutions, Siemens Healthineers, Athenahealth, GE Healthcare, Philips Healthcare and IBM Watson Health, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Medical Consortium market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medical Consortium and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical Consortium revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Medical Consortium market.

Medical Consortium Segment by Company

Epic Systems Corporation

Cerner Corporation

McKesson Corporation

Allscripts Healthcare Solutions

Siemens Healthineers

Athenahealth

GE Healthcare

Philips Healthcare

IBM Watson Health

Oracle Corporation

Agfa-Gevaert Group

Fujifilm Holdings Corporation

Medical Consortium Segment by Type

Clinical Integrated

Financial Integration Type

Information Integration Type

Medical Consortium Segment by Application

Patient Care Collaboration

Resource Sharing

Disease Management

Medical Consortium Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Medical Consortium status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Medical Consortium key companies, revenue, market share, and recent developments.

3. To split the Medical Consortium breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Medical Consortium market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Medical Consortium significant trends, drivers, influence factors in global and regions.

6. To analyze Medical Consortium competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Consortium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Consortium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Consortium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Consortium industry.

Chapter 3: Detailed analysis of Medical Consortium company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Medical Consortium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Medical Consortium in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Medical Consortium Industry Trends Table 2. Medical Consortium Industry Drivers Table 3. Medical Consortium Industry Opportunities and Challenges Table 4. Medical Consortium Industry Restraints Table 5. Global Medical Consortium Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Medical Consortium Revenue Share by Company (2021-2026) Table 7. Global Medical Consortium Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Medical Consortium Key Company Manufacturing Base & Headquarters Table 9. Global Medical Consortium Company, Product Type & Application Table 10. Global Medical Consortium Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Medical Consortium by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Clinical Integrated Table 15. Significant Companies of Financial Integration Type Table 16. Significant Companies of Information Integration Type Table 17. Global Medical Consortium Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Medical Consortium Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Medical Consortium Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Medical Consortium Sales Value Share by Type (2021-2026) Table 21. Global Medical Consortium Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Patient Care Collaboration Table 23. Significant Companies of Resource Sharing Table 24. Significant Companies of Disease Management Table 25. Global Medical Consortium Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Medical Consortium Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Medical Consortium Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Medical Consortium Sales Value Share by Application (2021-2026) Table 29. Global Medical Consortium Sales Value Share by Application (2027-2032) Table 30. Global Medical Consortium Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Medical Consortium Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Medical Consortium Sales Value Share by Region (2021-2026) Table 33. Global Medical Consortium Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Medical Consortium Sales Value Share by Region (2027-2032) Table 35. Global Medical Consortium Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Medical Consortium Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Medical Consortium Sales Value Market Share by Country (2021-2026) Table 38. Global Medical Consortium Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Medical Consortium Sales Value Market Share by Country (2027-2032) Table 40. Epic Systems Corporation Company Information Table 41. Epic Systems Corporation Business Overview Table 42. Epic Systems Corporation Medical Consortium Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Epic Systems Corporation Medical Consortium Product Portfolio Table 44. Epic Systems Corporation Recent Development Table 45. Cerner Corporation Company Information Table 46. Cerner Corporation Business Overview Table 47. Cerner Corporation Medical Consortium Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Cerner Corporation Medical Consortium Product Portfolio Table 49. Cerner Corporation Recent Development Table 50. McKesson Corporation Company Information Table 51. McKesson Corporation Business Overview Table 52. McKesson Corporation Medical Consortium Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. McKesson Corporation Medical Consortium Product Portfolio Table 54. McKesson Corporation Recent Development Table 55. Allscripts Healthcare Solutions Company Information Table 56. Allscripts Healthcare Solutions Business Overview Table 57. Allscripts Healthcare Solutions Medical Consortium Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Allscripts Healthcare Solutions Medical Consortium Product Portfolio Table 59. Allscripts Healthcare Solutions Recent Development Table 60. Siemens Healthineers Company Information Table 61. Siemens Healthineers Business Overview Table 62. Siemens Healthineers Medical Consortium Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Siemens Healthineers Medical Consortium Product Portfolio Table 64. Siemens Healthineers Recent Development Table 65. Athenahealth Company Information Table 66. Athenahealth Business Overview Table 67. Athenahealth Medical Consortium Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Athenahealth Medical Consortium Product Portfolio Table 69. Athenahealth Recent Development Table 70. GE Healthcare Company Information Table 71. GE Healthcare Business Overview Table 72. GE Healthcare Medical Consortium Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. GE Healthcare Medical Consortium Product Portfolio Table 74. GE Healthcare Recent Development Table 75. Philips Healthcare Company Information Table 76. Philips Healthcare Business Overview Table 77. Philips Healthcare Medical Consortium Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Philips Healthcare Medical Consortium Product Portfolio Table 79. Philips Healthcare Recent Development Table 80. IBM Watson Health Company Information Table 81. IBM Watson Health Business Overview Table 82. IBM Watson Health Medical Consortium Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. IBM Watson Health Medical Consortium Product Portfolio Table 84. IBM Watson Health Recent Development Table 85. Oracle Corporation Company Information Table 86. Oracle Corporation Business Overview Table 87. Oracle Corporation Medical Consortium Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Oracle Corporation Medical Consortium Product Portfolio Table 89. Oracle Corporation Recent Development Table 90. Agfa-Gevaert Group Company Information Table 91. Agfa-Gevaert Group Business Overview Table 92. Agfa-Gevaert Group Medical Consortium Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Agfa-Gevaert Group Medical Consortium Product Portfolio Table 94. Agfa-Gevaert Group Recent Development Table 95. Fujifilm Holdings Corporation Company Information Table 96. Fujifilm Holdings Corporation Business Overview Table 97. Fujifilm Holdings Corporation Medical Consortium Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Fujifilm Holdings Corporation Medical Consortium Product Portfolio Table 99. Fujifilm Holdings Corporation Recent Development Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. Medical Consortium Product Image Figure 2. Global Medical Consortium Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Consortium Market Size (2021-2032) & (US$ Million) Figure 4. Global Medical Consortium Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Clinical Integrated Image Figure 8. Financial Integration Type Image Figure 9. Information Integration Type Image Figure 10. Global Medical Consortium Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Medical Consortium Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Medical Consortium Sales Value Share by Type (2021-2032) Figure 13. Patient Care Collaboration Image Figure 14. Resource Sharing Image Figure 15. Disease Management Image Figure 16. Global Medical Consortium Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Medical Consortium Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Medical Consortium Sales Value Share by Application (2021-2032) Figure 19. Global Medical Consortium Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Medical Consortium Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Medical Consortium Sales Value (2021-2032) & (US$ Million) Figure 22. North America Medical Consortium Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Medical Consortium Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Medical Consortium Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Medical Consortium Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Medical Consortium Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Medical Consortium Sales Value (2021-2032) & (US$ Million) Figure 28. South America Medical Consortium Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Medical Consortium Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Medical Consortium Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Medical Consortium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Medical Consortium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Medical Consortium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Medical Consortium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Medical Consortium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Medical Consortium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Medical Consortium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Medical Consortium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Medical Consortium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Medical Consortium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Medical Consortium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Medical Consortium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Medical Consortium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Medical Consortium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Medical Consortium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Medical Consortium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Medical Consortium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Medical Consortium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Medical Consortium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Medical Consortium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Medical Consortium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Medical Consortium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Medical Consortium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Medical Consortium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Medical Consortium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Medical Consortium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Medical Consortium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Medical Consortium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Medical Consortium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Medical Consortium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Medical Consortium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Medical Consortium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Medical Consortium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Medical Consortium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Medical Consortium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Medical Consortium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Medical Consortium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Medical Consortium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Medical Consortium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Medical Consortium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Medical Consortium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Medical Consortium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Medical Consortium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Medical Consortium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Medical Consortium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Medical Consortium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Medical Consortium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Medical Consortium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Medical Consortium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Medical Consortium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Medical Consortium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Medical Consortium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Medical Consortium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Medical Consortium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Medical Consortium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Medical Consortium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Medical Consortium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Medical Consortium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Medical Consortium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Medical Consortium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Medical Consortium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Medical Consortium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Medical Consortium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Medical Consortium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Medical Consortium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Medical Consortium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Medical Consortium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Medical Consortium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Medical Consortium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Medical Consortium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Medical Consortium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Medical Consortium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Medical Consortium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Medical Consortium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Medical Consortium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Medical Consortium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Medical Consortium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Medical Consortium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Medical Consortium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Medical Consortium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Medical Consortium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Medical Consortium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Medical Consortium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Medical Consortium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Clinical Integrated
  • Financial Integration Type
  • Information Integration Type
Applications
  • Patient Care Collaboration
  • Resource Sharing
  • Disease Management
Companies covered
  • Epic Systems Corporation
  • Cerner Corporation
  • McKesson Corporation
  • Allscripts Healthcare Solutions
  • Siemens Healthineers
  • Athenahealth
  • GE Healthcare
  • Philips Healthcare
  • IBM Watson Health
  • Oracle Corporation
  • Agfa-Gevaert Group
  • Fujifilm Holdings Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Medical Consortium Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Medical Consortium Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Medical Consortium Market Dynamics
  1. 2.1 Medical Consortium Industry Trends
  2. 2.2 Medical Consortium Industry Drivers
  3. 2.3 Medical Consortium Industry Opportunities and Challenges
  4. 2.4 Medical Consortium Industry Restraints
3 Medical Consortium Market by Company
  1. 3.1 Global Medical Consortium Company Revenue Ranking in 2025
  2. 3.2 Global Medical Consortium Revenue by Company (2021-2026)
  3. 3.3 Global Medical Consortium Company Ranking (2024-2026)
  4. 3.4 Global Medical Consortium Company Manufacturing Base and Headquarters
  5. 3.5 Global Medical Consortium Company Product Type and Application
  6. 3.6 Global Medical Consortium Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Medical Consortium Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Medical Consortium Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Medical Consortium Market by Type
  1. 4.1 Medical Consortium Type Introduction
  2. 4.1.1 Clinical Integrated
  3. 4.1.2 Financial Integration Type
  4. 4.1.3 Information Integration Type
  5. 4.2 Global Medical Consortium Sales Value by Type
  6. 4.2.1 Global Medical Consortium Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Medical Consortium Sales Value by Type (2021-2032)
  8. 4.2.3 Global Medical Consortium Sales Value Share by Type (2021-2032)
5 Medical Consortium Market by Application
  1. 5.1 Medical Consortium Application Introduction
  2. 5.1.1 Patient Care Collaboration
  3. 5.1.2 Resource Sharing
  4. 5.1.3 Disease Management
  5. 5.2 Global Medical Consortium Sales Value by Application
  6. 5.2.1 Global Medical Consortium Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Medical Consortium Sales Value by Application (2021-2032)
  8. 5.2.3 Global Medical Consortium Sales Value Share by Application (2021-2032)
6 Medical Consortium Regional Value Analysis
  1. 6.1 Global Medical Consortium Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medical Consortium Sales Value by Region (2021-2032)
  3. 6.2.1 Global Medical Consortium Sales Value by Region: 2021-2026
  4. 6.2.2 Global Medical Consortium Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Medical Consortium Sales Value (2021-2032)
  7. 6.3.2 North America Medical Consortium Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Medical Consortium Sales Value (2021-2032)
  10. 6.4.2 Europe Medical Consortium Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Medical Consortium Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Medical Consortium Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Medical Consortium Sales Value (2021-2032)
  16. 6.6.2 South America Medical Consortium Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Medical Consortium Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Medical Consortium Sales Value Share by Country, 2025 VS 2032
7 Medical Consortium Country-level Value Analysis
  1. 7.1 Global Medical Consortium Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Medical Consortium Sales Value by Country (2021-2032)
  3. 7.2.1 Global Medical Consortium Sales Value by Country (2021-2026)
  4. 7.2.2 Global Medical Consortium Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Medical Consortium Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Medical Consortium Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Medical Consortium Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Medical Consortium Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Medical Consortium Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Medical Consortium Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Medical Consortium Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Medical Consortium Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Medical Consortium Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Medical Consortium Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Medical Consortium Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Medical Consortium Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Medical Consortium Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Medical Consortium Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Medical Consortium Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Medical Consortium Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Medical Consortium Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Medical Consortium Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Medical Consortium Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Medical Consortium Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Medical Consortium Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Medical Consortium Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Medical Consortium Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Medical Consortium Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Medical Consortium Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Medical Consortium Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Medical Consortium Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Medical Consortium Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Medical Consortium Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Medical Consortium Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Medical Consortium Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Medical Consortium Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Medical Consortium Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Medical Consortium Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Medical Consortium Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Medical Consortium Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Medical Consortium Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Medical Consortium Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Medical Consortium Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Medical Consortium Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Medical Consortium Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Medical Consortium Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Medical Consortium Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Medical Consortium Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Medical Consortium Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Medical Consortium Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Medical Consortium Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Medical Consortium Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Medical Consortium Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Medical Consortium Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Medical Consortium Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Medical Consortium Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Medical Consortium Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Medical Consortium Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Medical Consortium Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Medical Consortium Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Medical Consortium Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Medical Consortium Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Medical Consortium Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Medical Consortium Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Medical Consortium Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Medical Consortium Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Medical Consortium Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Medical Consortium Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Medical Consortium Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Medical Consortium Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Medical Consortium Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Medical Consortium Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Medical Consortium Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Medical Consortium Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Medical Consortium Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Medical Consortium Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Medical Consortium Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Medical Consortium Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Medical Consortium Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Medical Consortium Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Medical Consortium Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Medical Consortium Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Medical Consortium Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Medical Consortium Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Medical Consortium Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Medical Consortium Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Medical Consortium Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Medical Consortium Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Epic Systems Corporation
  2. 8.1.1 Epic Systems Corporation Company Information
  3. 8.1.2 Epic Systems Corporation Business Overview
  4. 8.1.3 Epic Systems Corporation Medical Consortium Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Epic Systems Corporation Medical Consortium Product Portfolio
  6. 8.1.5 Epic Systems Corporation Recent Developments
  7. 8.2 Cerner Corporation
  8. 8.2.1 Cerner Corporation Company Information
  9. 8.2.2 Cerner Corporation Business Overview
  10. 8.2.3 Cerner Corporation Medical Consortium Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Cerner Corporation Medical Consortium Product Portfolio
  12. 8.2.5 Cerner Corporation Recent Developments
  13. 8.3 McKesson Corporation
  14. 8.3.1 McKesson Corporation Company Information
  15. 8.3.2 McKesson Corporation Business Overview
  16. 8.3.3 McKesson Corporation Medical Consortium Revenue and Gross Margin (2021-2026)
  17. 8.3.4 McKesson Corporation Medical Consortium Product Portfolio
  18. 8.3.5 McKesson Corporation Recent Developments
  19. 8.4 Allscripts Healthcare Solutions
  20. 8.4.1 Allscripts Healthcare Solutions Company Information
  21. 8.4.2 Allscripts Healthcare Solutions Business Overview
  22. 8.4.3 Allscripts Healthcare Solutions Medical Consortium Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Allscripts Healthcare Solutions Medical Consortium Product Portfolio
  24. 8.4.5 Allscripts Healthcare Solutions Recent Developments
  25. 8.5 Siemens Healthineers
  26. 8.5.1 Siemens Healthineers Company Information
  27. 8.5.2 Siemens Healthineers Business Overview
  28. 8.5.3 Siemens Healthineers Medical Consortium Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Siemens Healthineers Medical Consortium Product Portfolio
  30. 8.5.5 Siemens Healthineers Recent Developments
  31. 8.6 Athenahealth
  32. 8.6.1 Athenahealth Company Information
  33. 8.6.2 Athenahealth Business Overview
  34. 8.6.3 Athenahealth Medical Consortium Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Athenahealth Medical Consortium Product Portfolio
  36. 8.6.5 Athenahealth Recent Developments
  37. 8.7 GE Healthcare
  38. 8.7.1 GE Healthcare Company Information
  39. 8.7.2 GE Healthcare Business Overview
  40. 8.7.3 GE Healthcare Medical Consortium Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GE Healthcare Medical Consortium Product Portfolio
  42. 8.7.5 GE Healthcare Recent Developments
  43. 8.8 Philips Healthcare
  44. 8.8.1 Philips Healthcare Company Information
  45. 8.8.2 Philips Healthcare Business Overview
  46. 8.8.3 Philips Healthcare Medical Consortium Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Philips Healthcare Medical Consortium Product Portfolio
  48. 8.8.5 Philips Healthcare Recent Developments
  49. 8.9 IBM Watson Health
  50. 8.9.1 IBM Watson Health Company Information
  51. 8.9.2 IBM Watson Health Business Overview
  52. 8.9.3 IBM Watson Health Medical Consortium Revenue and Gross Margin (2021-2026)
  53. 8.9.4 IBM Watson Health Medical Consortium Product Portfolio
  54. 8.9.5 IBM Watson Health Recent Developments
  55. 8.10 Oracle Corporation
  56. 8.10.1 Oracle Corporation Company Information
  57. 8.10.2 Oracle Corporation Business Overview
  58. 8.10.3 Oracle Corporation Medical Consortium Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Oracle Corporation Medical Consortium Product Portfolio
  60. 8.10.5 Oracle Corporation Recent Developments
  61. 8.11 Agfa-Gevaert Group
  62. 8.11.1 Agfa-Gevaert Group Company Information
  63. 8.11.2 Agfa-Gevaert Group Business Overview
  64. 8.11.3 Agfa-Gevaert Group Medical Consortium Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Agfa-Gevaert Group Medical Consortium Product Portfolio
  66. 8.11.5 Agfa-Gevaert Group Recent Developments
  67. 8.12 Fujifilm Holdings Corporation
  68. 8.12.1 Fujifilm Holdings Corporation Company Information
  69. 8.12.2 Fujifilm Holdings Corporation Business Overview
  70. 8.12.3 Fujifilm Holdings Corporation Medical Consortium Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Fujifilm Holdings Corporation Medical Consortium Product Portfolio
  72. 8.12.5 Fujifilm Holdings Corporation Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst